Helixgate

Premium Intelligence

Partnership Intelligence Briefings

Helixgate Partnership Intelligence Briefings are in‑depth editorial reports developed in collaboration with biotechnology innovators, research organizations, and technology leaders. These briefings explore emerging technologies, scientific breakthroughs, and the companies advancing the future of biotechnology and life‑science discovery.

Microplastics in Human Bile Drive Mitochondrial Dysfunction and Senescence

STAT+: Health insurers score major win with higher 2027 Medicare Advantage rates

Companies that sell Medicare Advantage plans will receive a 2.5% pay bump on average in 2027, up significantly from what was proposed and a win for an industry that has experienced higher medical costs and has opposed nearly all reforms to the lucrative taxpayer-financed program.

More importantly, the Trump administration scrapped its proposal that would have used more updated data in the payment process, ensuring that Medicare Advantage insurers retain billions of dollars.

In addition to base payments, Medicare Advantage insurers get paid based on how sick their members. This process is known as risk adjustment and has been flagged by watchdogs, auditors, and federal attorneys as rife with abuse. Trump officials proposed using newer data that goes into seniors’ “risk scores,” but after intense industry pushback over the past two months, they are dropping the proposal for now. 

Continue to STAT+ to read the full story…

Read More

CRISPR at 25: The Past, Present, and Future of Genome Editing

Immunotherapy Enhanced by Restoring Mitochondrial Function in Dendritic Cells

Hims & Hers says limited data stolen in social engineering attack

Proposed FDA budget sets Makary up to boost US biotech